MedPath

浙江贝得药业有限公司

Ownership
-
Established
2004-11-10
Employees
-
Market Cap
-
Website
http://www.betterpharma.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

18

NMPA:18

Drug Approvals

Lacidipine Dispersible Tablets

Product Name
拉西地平分散片
Approval Number
国药准字H20130129
Approval Date
Jul 14, 2023
NMPA

Omeprazole Sodium for Injection

Product Name
注射用奥美拉唑钠
Approval Number
国药准字H20084263
Approval Date
Mar 14, 2023
NMPA

Cefaclor Capsules

Product Name
头孢克洛胶囊
Approval Number
国药准字H20083278
Approval Date
Nov 14, 2022
NMPA

Clarithromycin Tablets

Product Name
克拉霉素片
Approval Number
国药准字H20083281
Approval Date
Nov 14, 2022
NMPA

Azithromycin Dispersible Tablets

Product Name
阿奇霉素分散片
Approval Number
国药准字H20083280
Approval Date
Oct 23, 2022
NMPA

Roxithromycin Capsules

Product Name
罗红霉素胶囊
Approval Number
国药准字H20083279
Approval Date
Oct 13, 2022
NMPA

Lacidipine

Product Name
拉西地平
Approval Number
国药准字H20083068
Approval Date
Aug 26, 2022
NMPA

Azithromycin for Injection

Product Name
注射用阿奇霉素
Approval Number
国药准字H20073769
Approval Date
May 25, 2022
NMPA

Famotidine for Injection

Product Name
注射用法莫替丁
Approval Number
国药准字H20073889
Approval Date
May 25, 2022
NMPA

Azithromycin for Injection

Product Name
注射用阿奇霉素
Approval Number
国药准字H20073770
Approval Date
May 25, 2022
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.